Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -43.26% is 34% above its 5-year average of -65.79%, around the middle of its 5-year range (-142.37%–8.65%).
112.79% below its 12-month average of -20.33%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -3.22%.
RETURN ON ASSETS (ROA)
-43.26%
RETURN ON ASSETS (ROA) AVG TTM
-20.33%
RETURN ON ASSETS (ROA) AVG 3Y
-69.16%
RETURN ON ASSETS (ROA) AVG 5Y
-65.79%
RETURN ON ASSETS (ROA) AVG 10Y
-111.49%
RETURN ON ASSETS (ROA) AVG 15Y
-58.28%
RETURN ON ASSETS (ROA) AVG 20Y
-131.38%
CURRENT VS TTM AVG
-112.79%
CURRENT VS 3Y AVG
+37.44%
CURRENT VS 5Y AVG
+34.24%
CURRENT VS 10Y AVG
+61.20%
CURRENT VS 15Y AVG
+25.77%
CURRENT VS 20Y AVG
+67.07%
SECTOR MEDIAN · HEALTHCARE
-31.88%
median of 840 covered companies
CURRENT VS SECTOR MEDIAN
-35.72%
vs the sector median at left
Scienture Holdings, Inc.
Market Cap
$5.69M
Return on Assets (ROA)
-43.26%
TTM Avg
-20.33%
3Y Avg
-69.16%
5Y Avg
-65.79%
Market Cap
$5.99M
Return on Assets (ROA)
-81.62%
TTM Avg
-81.33%
3Y Avg
-106.24%
5Y Avg
-102.80%
Market Cap
$5.85M
Return on Assets (ROA)
-102.86%
TTM Avg
-76.90%
3Y Avg
-95.53%
5Y Avg
-184.55%
Market Cap
$5.81M
Return on Assets (ROA)
83.82%
TTM Avg
-0.56%
3Y Avg
-31.49%
5Y Avg
-28.41%
Market Cap
$5.79M
Return on Assets (ROA)
-12.50%
TTM Avg
-23.99%
3Y Avg
-28.13%
5Y Avg
-27.65%
Market Cap
$6.26M
Return on Assets (ROA)
-99.97%
TTM Avg
-120.54%
3Y Avg
-89.96%
5Y Avg
-79.52%
Market Cap
$5.75M
Return on Assets (ROA)
-54.95%
TTM Avg
-72.19%
3Y Avg
-72.80%
5Y Avg
-69.14%
Market Cap
$6.32M
Return on Assets (ROA)
-55.85%
TTM Avg
-69.75%
3Y Avg
-63.38%
5Y Avg
-59.39%
Market Cap
$5.67M
Return on Assets (ROA)
-69.39%
TTM Avg
-57.20%
3Y Avg
-55.49%
5Y Avg
-56.22%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | $5.69M | -43.26% | -20.33% | -69.16% | -65.79% |
| Cardio Diagnostics Holdings, Inc. (CDIO)vs › | $5.99M | -81.62% | -81.33% | -106.24% | -102.80% |
| Lucyd, Inc (LUCY)vs › | $5.85M | -102.86% | -76.90% | -95.53% | -184.55% |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.81M | 83.82% | -0.56% | -31.49% | -28.41% |
| Sonoma Pharmaceuticals, Inc. (SNOA)vs › | $5.79M | -12.50% | -23.99% | -28.13% | -27.65% |
| Femasys Inc. (FEMY)vs › | $6.26M | -99.97% | -120.54% | -89.96% | -79.52% |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.75M | -54.95% | -72.19% | -72.80% | -69.14% |
| Biomerica, Inc. (BMRA)vs › | $6.32M | -55.85% | -69.75% | -63.38% | -59.39% |
| enVVeno Medical Corporation (NVNO)vs › | $5.67M | -69.39% | -57.20% | -55.49% | -56.22% |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.63M | -68.33% | -234.58% | -196.81% | -171.01% |
ROA
-43.3%
ROE
-59.2%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -49.31% |
| 2024-12-31 | 8.65% |
| 2023-12-31 | -142.37% |
| 2022-12-31 | -93.59% |
| 2021-12-31 | -92.19% |
| 2020-12-31 | -25.90% |
| 2019-12-31 | -5.11% |
| 2018-12-31 | 0.41% |
| 2017-12-31 | 46.80% |
| 2016-12-31 | -818.73% |
| 2015-12-31 | -55.10% |
| 2014-12-31 | -164.64% |
| 2013-12-31 | -517.82% |
| 2012-12-31 | -127.00% |
| 2011-12-31 | -2002.49% |
| 2008-12-31 | -4148.03% |
| 2007-12-31 | -1591.53% |
| 2006-12-31 | -66.23% |
| 2005-12-31 | 0.00% |
